| Before propensity score matching |  |  |  | After propensity score matching |  |  |  |
---|---|---|---|---|---|---|---|---|
Characteristic | Response to dose-1 (%) | p-value | Response to dose-2 (%) | p-value | Response to dose-1 (%) | p-value | Response to dose-2 (%) | p-value |
Male | 59 (71.08) | 0.198 | 78 (71.56) | 0.295 | 32 (71.1) | 0.365 | 46 (67.6) | 0.759 |
Hypertension | 38 (45.78) | 0.194 | 53 (48.62) | 0.252 | 29 (64.4) | 0.430 | 38 (55.8) | 0.419 |
Diabetes | 35 (42.17) | 0.898 | 49 (44.95) | 0.040 | 12 (26.6) | 0.108 | 25 (36.7) | 0.023 |
Triple regimen (TMP) | 27 (32.53) | 0.000 | 52 (47.71) | 0.000 | 21 (46.6) | 0.000 | 41 (60.2) | 0.003 |
Agea | 1.02 | 0.018 | 0.979 | 0.079 | 0.99 | 0.985 | 0.96 | 0.028 |
Time since Txa | 0.99 | 0.740 | 1.007 | 0.831 | 0.99 | 0.907 | 0.96 | 0.377 |
HBVb | 13 (24.53) | 0.605 | 17 (32.08) | 0.036 | 5 (33.3) | 0.201 | 6 (31.5) | 0.254 |